COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,440 Articles (22,835 medRxiv, 8,605 bioRxiv)

Most recent first Previous |  Page 1778: Articles 17771-17780  | Next

In vitro screening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
Tran, H., Peterburs, P., Seibel, J., Abramov-Sommariva, D., Lamy, E.
10.1101/2021.03.01.433344 — Posted: 2021-03-01
Risk factors for illness severity among pregnant women with confirmed SARS-CoV-2 infection - Surveillance for Emerging Threats to Mothers and Babies Network, 20 state, local, and territorial health departments, March 29, 2020 -January 8, 2021
Galang, R. R., Newton, S. M., Woodworth, K. R., Griffin, I., Oduyebo, T., Sancken, C. L., O'Malley Olsen, E., Aveni, K., Wingate, H., Shephard, H., Fussman, C., Alaali, Z. S., Siebman, S., Halai, U.-A., Delgado Lopez, C., Barton, J., Lush, M., Patrick, P. H., Schlosser, L., Sokale, A., Chaudhary, I., Reynolds, B., Sowunmi, S., Gaarenstroom, N., Read, J. S., Chicchelly, S., de Wilde, L., Azziz-Baumgartner, E., Hall, A. J., Tong, V. T., Ellington, S., Gilboa, S. M., CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team
10.1101/2021.02.27.21252169 — Posted: 2021-03-01
Trends in Thoracic Impedance and Arrhythmia Burden Among Patients with Implanted Cardiac Defibrillators During the COVID-19 Pandemic
Lu, Y., Murugiah, K., Jones, P., Caraballo, C., Mahajan, S., Massey, D., Rezwan, A., Bader, E., Krumholz, H.
10.1101/2021.02.27.21252559 — Posted: 2021-03-01
Physical Activity Patterns Among Patients with Intracardiac Remote Monitoring Devices Before, During, and After COVID-19-related Public Health Restrictions
Lu, Y., Murugiah, K., Jones, P., Massey, D., Mahajan, S., Caraballo, C., Rezwan, A., Bader, E., Krumholz, H.
10.1101/2021.02.27.21252558 — Posted: 2021-03-01
Effect of SARS-CoV-2 proteins on vascular permeability
Rauti, R., Shahoha, M., Leichtmann-Bardoogo, Y., Nasser, R., Tamir, R., Miller, V., Babich, T., Shaked, K., Ehrlich, A., Ioannidis, K., Nahmias, Y., Sharan, R., Ashery, U., Maoz, B. M.
10.1101/2021.02.27.433186 — Posted: 2021-03-01
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice
Case, J. B., Chen, R. E., Cao, L., Ying, B., Winkler, E. S., Goreshnik, I., Shrihari, S., Kafai, N. M., Bailey, A. L., Xie, X., Shi, P.-Y., Ravichandran, R., Carter, L., Stewart, L., Baker, D., Diamond, M. S.
10.1101/2021.03.01.433110 — Posted: 2021-03-01
Mice immunized with the vaccine candidate HexaPro spike produce neutralizing antibodies against SARS-CoV-2
Seephetdee, C., Buasri, N., Bhukhai, K., Srisanga, K., Manopwisedjaroen, S., Lertjintanakit, S., Phueakphud, N., Pakiranay, C., Kangwanrangsan, N., Srichatrapimuk, S., Sungkanuparph, S., Kirdlarp, S., Chutipongtanate, S., Thitithanyanont, A., Hongeng, S., Wongtrakoongate, P.
10.1101/2021.02.27.433054 — Posted: 2021-03-01
A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).
Rajczewski, A. T., Mehta, S., Ngyuen, D. D. A., Grüning, B. A., Johnson, J. E., McGowan, T. F., Griffin, T., Jagtap, P.
10.1101/2021.02.09.21251427 — Posted: 2021-03-01
Evaluating the trade-off between transmissibility and virulence of SARS-CoV-2 by mathematical modeling
Yang, H. M., Lombardi Junior, L. P. P., Yang, A. C.
10.1101/2021.02.27.21252592 — Posted: 2021-03-01
Modeling infection dynamics and mitigation strategies to support K-6 in-person instruction during the COVID-19 pandemic
Morrison, D. E., Nianogo, R., Manuel, V., Arah, O. A., Anderson, N., Kuo, T., Inkelas, M.
10.1101/2021.02.27.21252535 — Posted: 2021-03-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).